AbbVie concludes acquisition of Aliada Therapeutics Ruchika Sharma15 Dec 2024 10:00 AM ISTNorth Chicago, Ill: AbbVie has announced that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, Aliada...
AbbVie gets European Commission nod for Elahere for Platinum-Resistant ovarian cancer Ruchika Sharma19 Nov 2024 6:24 PM ISTNorth Chicago: AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) for...
AbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small cell lung cancer Ruchika Sharma29 Sept 2024 1:15 PM ISTNorth Chicago: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
AbbVie, FutureGen ink pact to develop Next-Generation Therapy for Inflammatory Bowel Disease Ruchika Sharma17 Jun 2024 12:30 PM ISTNorth Chicago, IlI.: AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have announced a license agreement to develop FG-M701, a next...
AbbVie concludes acquisition of Landos Biopharma Ruchika Sharma28 May 2024 2:30 PM ISTNorth Chicago, Ill.: AbbVie has announced that it has completed its acquisition of Landos Biopharma, Inc. With the completion of the acquisition,...
USFDA grants full approval for Abbvie Elahere for certain ovarian cancer patients Ruchika Sharma23 March 2024 1:15 PM ISTNorth Chicago, Ill.: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for ELAHERE...
AbbVie, OSE Immunotherapeutics collaborate to develop novel monoclonal antibody for Chronic Inflammation Ruchika Sharma3 March 2024 10:00 AM ISTUnder the terms of the agreement, AbbVie will receive an exclusive global license to develop, manufacture and commercialize OSE-230.
AbbVie, Tentarix collaborate to develop conditionally-active, multi-specific biologics for oncology, immunology Ruchika Sharma25 Feb 2024 12:45 PM ISTNorth Chicago: AbbVie Inc. and Tentarix Biotherapeutics have announced a multi-year collaboration focused on the discovery and development of...
AbbVie concludes acquisition of ImmunoGen Ruchika Sharma14 Feb 2024 4:36 PM ISTNorth Chicago, Ill.: AbbVie has announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition,...
AbbVie unveils Produodopa for Advanced Parkinson's Disease in EU Ruchika Sharma14 Jan 2024 1:00 PM ISTNorth Chicago, III.: AbbVie has announced the launch of PRODUODOPA (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced...
AbbVie, Umoja Biopharma collaborate to develop Novel In-Situ CAR-T Cell Therapies Ruchika Sharma8 Jan 2024 10:00 AM ISTNorth Chicago: AbbVie, and Umoja Biopharma, an early clinical-stage biotechnology company, have announced two exclusive option and license...
Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit Ruchika Sharma5 Jan 2024 4:15 PM ISTUnited States: A federal judge on Wednesday said Botox maker AbbVie's Allergan unit can move ahead with its lawsuit accusing Revance...
